THRIVE Study

Advertisement

cGxPJobs Banner

DBV Technologies Reports Positive VITESSE Data for VIASKIN Peanut Patch

CHÂTILLON, France, June 8, 2026 DBV Technologies announced new positive clinical findings from its Phase 3 VITESSE study evaluating...

By cGxPwire Editor
June 10, 2026

Read More

DBV Technologies Screens First Infant in THRIVE Peanut Allergy Study

CHÂTILLON, France and WARREN, N.J., June 2026 DBV Technologies announced that the first participant has been screened in the...

By cGxPwire Editor
June 5, 2026

Read More

Advertisement

cGxPJobs

Directory